                </a></li></ul></div><p><strong>Figure 3.  <span>CRC patients are able to mount CD4<sup>+</sup> T cell responses to the recall antigens PPD and HA.</span></strong></p><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1"></a><p>Whole PBMC from 11 age-matched controls and 14 CRC patients were assessed for responses to the antigens PPD and HA, measured by IFN-γ ELISPOT. Purified PBMC were added at 3.5×10<sup>5</sup> cells/well, and incubated for 18 hours in the presence of either 1 µg/ml PPD, 1 µg/ml HA or with no antigen. Wells were set up in duplicate. Fewer than 5 spot forming cells/10<sup>6</sup> PBMC was considered negative.</p>
<span>THISISTHEEND
